Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/10 → 31/12/12 |
Funding
- NHMRC - National Health and Medical Research Council (Australia): A$499,250.00
- NHMRC - National Health and Medical Research Council (Australia): A$99,850.00
Resolvin E1 is a novel anti-inflammatory and anti-fibrotic lipid mediator for the treatment of chronic kidney desease.
- Li, Jinhua (Primary Chief Investigator (PCI))
- Nikolic-Paterson, David (Chief Investigator (CI))
Project: Research